Ory Wiesel

Dr. Ory Wiesel

Thoracic Surgery, Poriya Medical Center, Tabarīya, Israel
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2023 in Biosensors
Verified
Journal Article
Open access
PDF file
OWOry Wiesel
Ory Wiesel
SSSookwhan Sung
Sookwhan Sung
AKAmit Katz
Amit Katz
RLRaya Leibowitz
Raya Leibowitz
JBJair Bar
Jair Bar
MDMichal Mark Danieli
Michal Mark Danieli
Lung cancer is the leading cause of cancer-related mortality worldwide. Early detection is essential to achieving a better outcome and prognosis. Volatile organic compounds (VOCs) reflect alterations in the pathophysiology and body metabolism processes, as shown in various types of cancers. The biosensor platform (BSP) urine test uses animals’ unique, proficient, and accurate ability to scent lung cancer VOCs. The BSP is a testing platform for the binary (negative/positive) recognition of the signature VOCs of lung cancer by trained and qualified Long–Evans rats as biosensors (BSs). The results of the current double-blind study show high accuracy in lung cancer VOC recognition, with 93% sensitivity and 91% specificity. The BSP test is safe, rapid, objective and can be performed repetitively, enabling periodic cancer monitoring as well as an aid to existing diagnostic methods. The future implementation of such urine tests as routine screening and monitoring tools has the potential to significantly increase detection rate as well as curability rates with lower healthcare expenditure. This paper offers a first instructive clinical platform utilizing VOC’s in urine for detection of lung cancer using the innovative BSP to deal with the pressing need for an early lung cancer detection test tool.

31 October 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Walid ShalataWalid Shalata
Walid Shalata
SDSameh Daher
Sameh Daher
NRNatalie Rabinovich
Natalie Rabinovich
SSSivan Shamai
Sivan Shamai
WKWaleed Kian
Waleed Kian
Abed AgbaryaAbed Agbarya
Abed Agbarya
Background: Lung cancer is among the most prevalent and serious forms of cancer, characterized by an allogenic phenotype that presents significant therapeutic challenges. Materials and Methods: We analyzed medical records from January 2022 to August 2023, focusing on individuals aged 18 and older diagnosed with resectable NSCLC who received neoadjuvant chemo-immunotherapy prior to surgical intervention. Results: The cohort comprised 56 patients, predominantly smokers (95%) and male (74%), with 80% presenting the disease at stage III. Of the participants, 44 underwent surgery, with 95% receiving lobar resection. Clinical assessments via PET-CT imaging revealed an 86% rate of response or disease stabilization, while pathological evaluations showed complete and major pathological responses in 61% of cases. Conclusions: This real-world data supports the safety and efficacy of incorporating immune checkpoint inhibitors in the neoadjuvant treatment of NSCLC, followed by surgical resection.

1 August 2023 in BJR|Open
Verified
Journal Article
Open access
NTNir Tsur
Nir Tsur
ESElla Segal
Ella Segal
NKNoga Kurman
Noga Kurman
STSharon Tzelnick
Sharon Tzelnick
OWOry Wiesel
Ory Wiesel
HSHagit Shoffel-Havakuk
Hagit Shoffel-Havakuk
Objective: To evaluate patient characteristics, risk factors, disease course, and management of cervical vertebral osteomyelitis in patients who had radiation for head and neck cancers. Methods: A retrospective cohort study (case series) of patients diagnosed with post-radiation osteomyelitis of the cervical spine between 2012 and 2021. Data were collected from the patient’s medical files. Results: Seven patients (71% male) with post-radiation cervical osteomyelitis were reviewed. The median patient age was 64 years. The mean interval between diagnosis of osteomyelitis and the first and last radiotherapy course was 8.3 and 4.0 years, respectively. A medical or surgical event preceded the diagnosis in four patients (57%) by a mean of 46.25 days. Common imaging findings were free air within the cervical structures and fluid collection. Four patients recovered from osteomyelitis during the follow-up within an average of 65 days. Conclusion: Post-radiation osteomyelitis is characterized by a subtle presentation, challenging diagnosis, prolonged treatment, and poor outcome. Clinicians should maintain a high index of suspicion for the long-term after radiotherapy. Multidisciplinary evaluation and management are warranted. Advances in knowledge: The study describes post-radiotherapy osteomyelitis of the cervical spine, a rare and devastating complication. Literature data regarding this complication are sparse.

1 February 2020 in Journal of Laparoendoscopic & Advanced Surgical Techniques
Verified
Journal Article
Closed access
OWOry Wiesel
Ory Wiesel
JSJason P. Shaw
Jason P. Shaw
JRJoshua Ramjist
Joshua Ramjist
IBIgor Brichkov
Igor Brichkov
DSDanny A. Sherwinter
Danny A. Sherwinter
Every field of surgery has seen an explosion of new technologies aimed at improving surgical technique and reducing complications. The use of near-infrared (NIR) fluorescence to assess perfusion has been described in several surgical disciplines. NIR provides the surgeon with real-time perfusion assessment of a target organ or anastomosis and can be invaluable in aiding decision-making during the index operation. In the following article we discuss the use of fluorescence-guided perfusion assessment during colonic interposition for esophageal replacement. To our knowledge this is the first description of the use of fluorescence-guided perfusion assessment during colonic interposition.

7 January 2022 in Cureus
Verified
Journal Article
Open access
RSRatnam K. Santoshi
Ratnam K. Santoshi
PKPrarthna Chandar Kulandaisamy
Prarthna Chandar Kulandaisamy
SGSushilKumar S. Gupta
SushilKumar S. Gupta
YKYizhak Kupfer
Yizhak Kupfer
OWOry Wiesel
Ory Wiesel
Pleural space infections have been described since the time of Hippocrates and to this day remains a significant pathology. Every year in the USA approximately there are one million hospital admissions for pneumonia with 20%-40% associated with some form of pleural space infections leading to pleural effusions with increased morbidity and mortality. Often, management of these effusions mandate combination of medical treatment and surgical drainage with debridement and decortication. There has been a lot of ongoing research regarding the safety and efficacy of intrapleural fibrinolytics in the management of complicated pleural effusions and empyema. Till this day, areas of debate and controversies exist among clinicians treating pleural space infection. Empyema is historically considered a surgical disease. There have been societies and guidelines for the management of infected parapneumonic effusions with antibiotics and chest tube drainage as an initial empiric treatment modality. With the advances in the use of Intrapleural fibrinolytics and minimally invasive procedures such as video-assisted thoracoscopic surgery (VATS), empyema a surgical disease is now more favoring medical management. Surgical option, such as open thoracotomy, is reserved for patients who failed conservative management and chronic empyema. The aim of this comprehensive review is to shed light on the evolution of various management strategies from the era of Hippocrates to current day practice and how there continues to be a paradigm shift in treating empyema as a surgical condition to a medical disease.

1 October 2022 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
OWOry Wiesel
Ory Wiesel
DKDaniel Kaufman
Daniel Kaufman
CCCaralee Caplan-Shaw
Caralee Caplan-Shaw
JSJason Shaw
Jason Shaw
Original Article Perspective and practice patterns of mediastinal staging among thoracic surgeons Ory Wiesel, Daniel Kaufman, Caralee Caplan-Shaw, Jason Shaw